Functional assay.
Anti-CD20 MAbs rituximab and ofatumumab induce CDC while obinutuzumab is less effective. The effect of active human serum on MAbs induced CDC was evaluated in Ramos (A) and MEC-1 (B) cells.
Immunohistochemistry.
Immunohistochemical analyses using C20Mab for OSCC or normal lymph node. (A and B).
Reduce the number of B cells The number of CD19+ cells in the spleen and (B) cervical and inguinal lymph nodes following treatment with SC or IV ocrelizumab or ofatumumab.
Functional assay.
Anti-CD20 MAbs rituximab and ofatumumab induce CDC while obinutuzumab is less effective. The effect of active human serum on MAbs induced CDC was evaluated in Ramos (A) and MEC-1 (B) cells.
Immunohistochemistry.
Immunohistochemical analyses using C20Mab for OSCC or normal lymph node. (A and B).
Reduce the number of B cells The number of CD19+ cells in the spleen and (B) cervical and inguinal lymph nodes following treatment with SC or IV ocrelizumab or ofatumumab.
My Review for Anti-Human CD20 (Ofatumumab) monoclonal antibody, Functional Grade
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.